pI: 8.7699 |
Length (AA): 964 |
MW (Da): 109194 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
14 | 783 | 4kvm (A) | 6 | 682 | 33.00 | 0 | 1 | 0.955555 | 0.56 |
15 | 143 | 2xcb (A) | 33 | 159 | 10.00 | 0 | 0.85 | 0.395817 | -1.17 |
22 | 854 | 4xnh (A) | 24 | 784 | 24.00 | 0 | 1 | 0.812108 | 0.88 |
50 | 139 | 3ma5 (A) | 59 | 148 | 17.00 | 0 | 0.92 | 0.428361 | -1.42 |
793 | 955 | 5cwf (A) | 4 | 173 | 9.00 | 0.77 | 0.13 | 0.265387 | -0.73 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | ME49 merozoite. | Hehl AB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | VEG Tachyzoite, ME49 Tachyzoite. | Gregory |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | ME49 Oocyst, ME49 Bradyzoite. | Fritz HM Sibley/Greg |
Gregory | ToxoDB |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Sibley/Greg | ToxoDB |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Ortholog group members (OG5_127529)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G80410 | protein EMBRYO DEFECTIVE 2753 |
Babesia bovis | BBOV_IV011250 | tetratricopeptide repeat containing domain protein |
Brugia malayi | Bm1_44550 | TPR Domain containing protein |
Candida albicans | CaO19.10695 | protein N-acetyltransferase subunit |
Candida albicans | CaO19.3185 | protein N-acetyltransferase subunit |
Caenorhabditis elegans | CELE_Y50D7A.4 | Protein HPO-29 |
Cryptosporidium hominis | Chro.70115 | hypothetical protein |
Cryptosporidium hominis | Chro.70114 | hypothetical protein |
Cryptosporidium parvum | cgd7_920 | protein with 2 possible TPR domains, possible n-terminal acetyltransferase |
Dictyostelium discoideum | DDB_G0275075 | tetratricopeptide-like helical domain-containing protein |
Drosophila melanogaster | Dmel_CG12202 | NAT1 ortholog (S. cerevisiae) |
Echinococcus granulosus | EgrG_000817600 | n alpha acetyltransferase 15 NatA auxiliary |
Entamoeba histolytica | EHI_000930 | hypothetical protein, conserved protein |
Entamoeba histolytica | EHI_098390 | hypothetical protein, conserved |
Echinococcus multilocularis | EmuJ_000817600 | n alpha acetyltransferase 15, NatA auxiliary |
Homo sapiens | ENSG00000164134 | N(alpha)-acetyltransferase 15, NatA auxiliary subunit |
Homo sapiens | ENSG00000172766 | N(alpha)-acetyltransferase 16, NatA auxiliary subunit |
Leishmania braziliensis | LbrM.35.1450 | N-acetyltransferase subunit Nat1, putative |
Leishmania donovani | LdBPK_361390.1 | N-acetyltransferase subunit Nat1, putative |
Leishmania infantum | LinJ.36.1390 | N-acetyltransferase subunit Nat1, putative |
Leishmania major | LmjF.36.1340 | N-acetyltransferase subunit Nat1, putative |
Leishmania mexicana | LmxM.36.1340 | N-acetyltransferase subunit Nat1, putative |
Loa Loa (eye worm) | LOAG_07419 | hypothetical protein |
Loa Loa (eye worm) | LOAG_06579 | hypothetical protein |
Mus musculus | ENSMUSG00000022020 | N(alpha)-acetyltransferase 16, NatA auxiliary subunit |
Mus musculus | ENSMUSG00000063273 | N(alpha)-acetyltransferase 15, NatA auxiliary subunit |
Neospora caninum | NCLIV_048770 | N-terminal acetyltransferase complex subunit NARG1, putative |
Oryza sativa | 4326606 | Os01g0617500 |
Plasmodium berghei | PBANKA_1457400 | N-alpha-acetyltransferase 15, NatA auxiliary subunit, putative |
Plasmodium falciparum | PF3D7_1244100 | N-alpha-acetyltransferase 15, NatA auxiliary subunit, putative |
Plasmodium knowlesi | PKNH_1463400 | N-alpha-acetyltransferase 15, NatA auxiliary subunit, putative |
Plasmodium vivax | PVX_101105 | hypothetical protein, conserved |
Plasmodium yoelii | PY01215 | unnamed protein product |
Plasmodium yoelii | PY06007 | acetyltransferase Tubedown-1 |
Saccharomyces cerevisiae | YDL040C | Nat1p |
Schistosoma japonicum | Sjp_0123290 | ko:K00670 peptide alpha-N-acetyltransferase [EC2.3.1.88], putative |
Schistosoma japonicum | Sjp_0310150 | NMDA receptor-regulated protein 1, putative |
Schistosoma japonicum | Sjp_0305930 | NMDA receptor-regulated 1-like protein, putative |
Schistosoma mansoni | Smp_062520 | n-terminal acetlytransferase-related |
Schmidtea mediterranea | mk4.036643.00 | N-terminal acetlytransferase-related |
Schmidtea mediterranea | mk4.006548.00 | N-terminal acetlytransferase-related |
Trypanosoma brucei gambiense | Tbg972.10.6890 | N-acetyltransferase subunit Nat1, putative |
Trypanosoma brucei | Tb927.10.5670 | N-acetyltransferase subunit Nat1, putative |
Trypanosoma congolense | TcIL3000_10_4810 | N-acetyltransferase subunit Nat1, putative |
Trypanosoma cruzi | TcCLB.510301.80 | N-acetyltransferase subunit Nat1, putative |
Trypanosoma cruzi | TcCLB.504163.110 | N-acetyltransferase subunit Nat1, putative |
Toxoplasma gondii | TGME49_223710 | tetratricopeptide repeat-containing protein |
Theileria parva | TP01_1184 | hypothetical protein |
Trichomonas vaginalis | TVAG_473860 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_211340 | O-linked N-acetylglucosamine transferase, ogt, putative |
Trichomonas vaginalis | TVAG_437210 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.5670 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.5670 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.5670 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.5670 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_Y50D7A.4 | Caenorhabditis elegans | embryonic lethal | wormbase |
TGME49_223710 this record | Toxoplasma gondii | Probably essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.